| Name | 5-(4-Chlorophenyl)-3,3'-bipyridine-6,6'-diamine dihydrochloride |
|---|---|
| Synonyms |
5-(4-Chlorophenyl)-3,3'-bipyridine-6,6'-diamine dihydrochloride
[3,3'-Bipyridine]-6,6'-diamine, 5-(4-chlorophenyl)-, hydrochloride (1:2) |
| Description | PF 6260933 is a potent, selective and orally bioavailable MAP4K4 inhibitor with kinase IC50 of 3.7 nM, cell IC50 of 160 nM; possesses excellent kinome selectivity and suitable properties for in vivo pharmacological characterization; significantly improves fasting hyperglycemia (44% reduction in blood glucose, 10 mg/kg, bid); also markedly reduces atherosclerotic lesion area in mice. |
|---|---|
| References | References 1. Ammirati M, et al. ACS Med Chem Lett. 2015 Oct 6;6(11):1128-33. 2. Roth Flach RJ, et al. Nat Commun. 2015 Dec 21;6:8995. View Related Products by Target MAP4K |
| Molecular Formula | C16H15Cl3N4 |
|---|---|
| Molecular Weight | 369.676 |
| Exact Mass | 368.036224 |